Predictors of short-term readmission after beyond total mesorectal excision for primary locally advanced and recurrent rectal cancer

AbstractUnplanned readmissions heavily affect the cost of health care and are used as an indicator of performance. No clear data are available regarding beyond-total mesorectal excision (bTME) procedure. Aim of the study is to identify patient-related and surgery-related factors influencing the 30-day readmissions after bTME. Retrospective data were collected from 220 patients who underwent bTME procedures at single centre between 2006 and 2016. Patient-related and operative factors were assessed, including body mass index (BMI), age, gender, American Society of Anaesthesiologists ’ (ASA) score, preoperative stage, neo-adjuvant therapy, primary tumour vs recurrence, the extent of surgery. The readmission rate was 8.18%. No statistically significant association was found with BMI, ASA score, length of stay and stay in the intensive care unit, primary vs recurrent tumour or b lood transfusions. Not quite statistically significant was the association with pelvic side wall dissection (OR 3.32,p = 0.054). Statistically significant factors included preoperative stage >  IIIb (OR: 4.77,p = 0.002), neo-adjuvant therapy (OR: 0.13,p = 0.0006), age over 65 years (OR: 5.96,p = 0.0005), any re-intervention during the first admission (OR: 7.4,p = 0.0001), and any post-operative complication (OR: 9.01,p = 0.004). The readmission rate after beyond-TME procedure is influenced by patient-related factors as well as post-operative morbidity.
Source: Updates in Surgery - Category: Surgery Source Type: research